Kelly is a Post-Doctoral Research Associate in Dr Samantha Terry's group focusing on molecular radionuclide therapy in neuroendocrine cancer. Prior to working in the Terry group, Kelly obtained her bachelor’s and master’s degree from the University of Leeds. Kelly completed her PhD, followed by a Post-Doctoral Research position, at the University of Hull.